Tamoxifen Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy
Condition:   Ovarian Cancer Intervention:   Drug: Pamiparib/Tamoxifen Sponsor:   Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2023 Category: Research Source Type: clinical trials

Preoperative Window of Opportunity Study With Giredestrant (GDC-9545) or Tamoxifen in Premenopausal Women With ER[+]/HER2[-] & Ki67 ≥10% Early Breast Cancer
Conditions:   Breast Cancer;   Breast Cancer, Early-Onset Interventions:   Drug: Giredestrant;   Drug: Tamoxifen Sponsor:   MedSIR Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials